Label-free isolation of prostate circulating tumor cells using Vortex microfluidic technology
Prostate cancer: a “liquid biopsy” test for circulating tumor cells A microfluidic device can rapidly and efficiently isolate circulating tumor cells from the blood of prostate cancer patients. Elodie Sollier-Christen of Vortex Biosciences, Rajan Kulkarni of David Geffen School of Medicine at UCLA,...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2017-05-01
|
Series: | npj Precision Oncology |
Online Access: | https://doi.org/10.1038/s41698-017-0015-0 |